Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Earnings Yield Over TimeElevated
Percentile Rank93
3Y CAGR+28.3%
Studio
Year-over-Year Change

Earnings yield ratio

3Y CAGR
+28.3%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.80%-32.1%
20241.17%+119.8%
2023-5.93%-1672.5%
20220.38%+101.8%
2021-21.02%-587.1%
2020-3.06%+32.0%
2019-4.50%-98.7%
2018-2.26%+22.5%
2017-2.92%+80.4%
2016-14.88%-